XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.270
-0.020 (-0.87%)
At close: Jul 17, 2026, 4:00 PM EDT
2.310
+0.040 (1.76%)
After-hours: Jul 17, 2026, 5:22 PM EDT
XBiotech Market Cap
XBiotech has a market cap or net worth of $69.21 million as of July 17, 2026. Its market cap has decreased by -23.86% in one year.
Market Cap
69.21M
Enterprise Value
-46.25M
1-Year Change
-23.86%
Ranking
Category
Stock Price
$2.27
ChartMarket Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $69.21M, a decrease of -90.61%. That is a compound annual growth rate of -18.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 69.20M | -5.08% |
| Dec 31, 2025 | 72.90M | -39.45% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 74.96M |
| OKYO Pharma | 74.26M |
| Annovis Bio | 74.02M |
| Gain Therapeutics | 72.94M |
| MindWalk Holdings | 72.26M |
| PMV Pharmaceuticals | 71.20M |
| Pliant Therapeutics | 70.97M |
| iBio, Inc. | 70.05M |